Secondary hypertrophic osteoarthropathy (Q88682): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/1325516156
@@ Property / Canonical URI: https://id.who.int/icd/entity/1325516156 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_1325516156
@@ Property / CURIE: CID11:ID_1325516156 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_1325516156
@@ Property / Canary Token: dki-india-ID_1325516156 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank

Latest revision as of 15:04, 15 August 2026

Sporadic hypertrophic osteoarthropathy has been described in association with a large number of malignancies of which bronchial carcinoma is the commonest and with a wide range of non-malignant disorders including congenital cyanotic heart disease, chronic pulmonary disease, especially cystic fibrosis and chronic liver diseases. It is much commoner than primary hypertrophic osteoarthropathy.

Language	Label	Description	Also known as
default for all languages	ID_1325516156
English	Secondary hypertrophic osteoarthropathy	Sporadic hypertrophic osteoarthropathy has been described in association with a large number of malignancies of which bronchial carcinoma is the commonest and with a wide range of non-malignant disorders including congenital cyanotic heart disease, chronic pulmonary disease, especially cystic fibrosis and chronic liver diseases. It is much commoner than primary hypertrophic osteoarthropathy.